Rankings
▼
Calendar
NVCR Q3 2016 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q3 2016 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$22M
Gross Profit
$11M
48.7% margin
Operating Income
-$28M
-130.4% margin
Net Income
-$34M
-155.2% margin
EPS (Diluted)
$-0.39
QoQ Revenue Growth
+21.0%
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$38M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$291M
Total Liabilities
$133M
Stockholders' Equity
$158M
Cash & Equivalents
$116M
Geographic Segments
UNITED STATES
$18M
84%
E M E A
$4M
16%
JAPAN
$24,000
0%
← FY 2016
All Quarters
Q4 2016 →